Cargando…
Intratumoral Immunotherapy and Tumor Ablation: A Local Approach with Broad Potential
SIMPLE SUMMARY: The goal of immuno-oncology is to potentiate a durable antitumor immune response. The immunosuppressive tumor microenvironment (TME) presents a substantial challenge to current systemic therapies due in part to a lack of available tumor antigen, dense stroma, an abundance of immunosu...
Autores principales: | Senders, Zachary J., Martin, Robert C. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996835/ https://www.ncbi.nlm.nih.gov/pubmed/35406525 http://dx.doi.org/10.3390/cancers14071754 |
Ejemplares similares
-
Trial watch: intratumoral immunotherapy
por: Humeau, Juliette, et al.
Publicado: (2021) -
Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST
por: Goldmacher, Gregory V., et al.
Publicado: (2020) -
Immunotherapeutic Agents for Intratumoral Immunotherapy
por: Shyr, Chih-Rong, et al.
Publicado: (2023) -
Maximizing response to intratumoral immunotherapy in mice by tuning local retention
por: Momin, Noor, et al.
Publicado: (2022) -
The Contemporary Landscape and Future Directions of Intratumoral Immunotherapy
por: Brito-Orama, Sebastian, et al.
Publicado: (2023)